The fact that these individuals had lifelong epilepsy and temporal lobe resections may mean that these results do not generalize to most patients with AD who develop seizures, but the identification of phosphorylated tau in the brain tissue of patients with chronic epilepsy does underscore the potential shared neuropathology between patients with chronic epilepsy and those with AD. The gene discussed is MAPT; the disease is epilepsy.